GRANDEURY ARNAUD,TUFILLI NICOLA,FAIRHURST ROBIN ALEC,ACHOUR MILOUD,HATAKEYAMA SHINJI,KOZICZAK-HOLBRO MAGDALENA,ULLRICH THOMAS
申请号：
CL2015001940
公开号：
CL2015001940A1
申请日:
2015.07.08
申请国别(地区):
CL
年份:
2015
代理人:
摘要：
A Solid oral Pharmaceutical composition comprising from 0.01 to 15% by weight of (R) - 7 - (2 - (1 - (4 - Butoxy - phenyl) - 2 - (propan-2-yl Methyl amino) - 1 - hydroxy ethyl) - 5 - hydroxy - benzo [d] - thiazole - 2 (3H) - One and excipients, wherein the compound is in the form of acetate salt； its Manufacturing Method, useful for T Treatment or prevention of muscular dystrophy or cachexia, among others.LA SOLICITUD SE REFIERE A UNA COMPOSICIÓN FARMACÉUTICA ORAL SÓLIDA QUE COMPRENDE 0,01 A 15 % EN PESO DE ACETATO DE R-7(2-(1-(4-BUTOXI-FENIL)-2-BUTIL-PROPAN-2-IL-AMINO)-1-HIDROXI-ETIL)-5-HIDROXI-BENZO[D]TIAZOL-2(3H)-ONA, A UN MÉTODO DE FABRICACIÓN Y A SU USO EN EL TRATAMIENTO O PREVENCIÓN DE DISTROFIA MUSCULAR, ATROFIA POR DESUSO, CAQUEXIA O SARCOPENIA
